Physician profile
Kathleen Lutz
NPI 1306930235
$22,544.73
in general payments reported to CMS, 2019-2025
12 companies · $3,413 in 2025
The $3,413 reported for 2025 was more than what 99% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,618 · 2022: $2,624 · 2023: $4,474 · 2024: $6,416 · 2025: $3,413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,411 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,640 · Travel and Lodging: $1,789 · Food and Beverage: $1,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,411.41 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,640.00 |
| Travel and Lodging | $1,788.82 |
| Food and Beverage | $1,462.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $8,993.90 | 2021-2024 | Imfinzi, Lynparza |
| Pfizer INC. | $3,500.00 | 2024 | |
| Glaxosmithkline, LLC. | $2,925.76 | 2021-2025 | Zejula |
| Eisai INC. | $1,660.00 | 2021-2023 | |
| Abbvie INC. | $1,503.84 | 2024 | |
| Corcept Therapeutics | $1,316.77 | 2025 | |
| Incyte Corporation | $1,268.59 | 2022 | |
| Genmab U.S., INC. | $735.00 | 2025 | Epkinly |
| Merck Sharp & Dohme LLC | $247.42 | 2023-2025 | Keytruda |
| Immunogen, INC. | $213.71 | 2023 | Elahere |
| Seagen INC. | $156.21 | 2022-2023 | Tivdak |
| Verastem, INC. | $23.53 | 2025 | Avmapki Fakzynja Co-Pack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Lutz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.